KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

A patient-centered approach is recommended to tailor to individual needs when calculating individual protein needs.

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those ...

(HealthDay News) — Time-restricted eating (TRE) may not add additional benefit in visceral adipose tissue reduction over the Mediterranean diet for people with overweight or obesity, according to a ...

(HealthDay News) — There is considerable uncertainty regarding the effects of puberty blockers in young individuals experiencing gender dysphoria (GD), according to two reviews published online in the ...

(HealthDay News) — Adults aged 18 to 49 years reporting medical-only or medical-nonmedical cannabis use may have a higher prevalence of cannabis use disorder (CUD) than those reporting nonmedical only ...

An Alabama woman has become the longest-living recipient of a pig organ transplant, passing 60 days with a gene-edited kidney and showing no signs of slowing down. “I’m superwoman,” Towana Looney, 53, ...

Using multiparametric MRI in place of TURBT in the initial staging of new bladder cancers can expedite treatment of ...

Discrepancies in causes of death were found when reviewing medical records vs death certificate data among patients with AAV.

(HealthDay News) — Heart disease continues to be a leading cause of death, according to a report from the American Heart Association published online in Circulation.

Children with AAV and kidney disease face increased risks for long-term renal damage at 1 year, despite the majority achieving inactive renal disease by this time.

Some patients with low-grade Ta nonmuscle-invasive bladder cancer (LG Ta NMIBC) can experience recurrence after many years.